Gene symbol | CCDC15 |
---|---|
Aliases | |
Protein Name | |
Function | |
Species | Human |
Editing Sites | 4 |
Disease | Tumorigenesis; |
Description | Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppressive, respec- tively. More importantly, ADARs-mediated splicing changes indeed affect tumorigenesis, not merely byproducts of ADARs editing and binding. |
RADR | RADAR |
REDIportal | REDI portal |
External links | (Uniport); (NM id); (NCBI gene id); GeneCard; GTEx |
Sequence |
Enzyme | Editing type | Region | NT Seq Position | Molecular Consequence | Editing Level | Tissue | Editing Effect | Phenotype | Disease name | PMID |
---|---|---|---|---|---|---|---|---|---|---|
|
A-to-I | intronic | chr11:124996215 | Alternative splicing change | Presence | EC109 cells; HEK293T cells | Alternative splicing change | Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppress | ||
|
A-to-I | intronic | chr11:124996219 | Alternative splicing change | Presence | EC109 cells; HEK293T cells | Alternative splicing change | Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppress | ||
|
A-to-I | intronic | chr11:124996223 | Alternative splicing change | Presence | EC109 cells; HEK293T cells | Alternative splicing change | Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppress | ||
|
A-to-I | intronic | chr11:124996224 | Alternative splicing change | Presence | EC109 cells; HEK293T cells | Alternative splicing change | Exon 9-included CCDC15 and exon 3-included RELL2 isoforms are oncogenic and tumor suppress |